Patent Assignment
Reel/Frame 012828/0928
Change of Name
Recorded: 2002-04-12
Received: 2002-04-30
Pages: 17
Assignor
AMERICAN HOME PRODUCTS CORPORATION
Executed: 2002-03-11
Assignee
WYETH
FIVE GIRALDA FARMS, MADISON, NJ, 07940, UNITED STATES
Covered Properties
(100)
Methods and compositions for inhibiting the function of polynucleotide sequence
Application:
10/009,134 →
Cycloalkyl-Substituted Aryl-Piperazines, Piperidines and Tetrahydropyridines as Serotonergic Agents
Application:
10/107,866 →
Diaminopyridine-Containing Thiourea Inhibitors of Herpes Viruses
Application:
10/099,695 →
4-Substituted-3-Substituted-Amino-Cyclobut-3-Ene-1,2-Diones and Analogs Thereof as Novel Potassium Channel Openers
Application:
10/095,392 →
4-Substituted-3-Substituted-Amino-Cyclobut-3-Ene-1,2-Diones and Analogs Thereof as Novel Potassium Channel Openers
Application:
10/098,140 →
Vesicular Complexes and Methods of Making and Using the Same
Application:
90/006,245 →
Methods of Inhibiting Sphincter Incontinence
Application:
10/087,248 →
Composition and method for humane euthanasia of animals
Application:
60/358,467 →
Pyrrolylalkylidene-hydrazinecarboxidamide derivatives as 5-hydroxytryptamine-6 ligands
Application:
60/357,032 →
Human Potassium Channel Polynucleotides and Polypeptides and Uses Thereof
Application:
10/062,879 →
Preparation and Purification of Antiviral Disulfonic Acid Disodium Salt
Application:
10/066,356 →
Stablized difloxacin injectable solution
Application:
60/352,764 →
1-Aryl-Or 1-Alkylsulfonylbenzazole Derivatives as 5-Hydroxytryptamine-6 Ligands
Application:
10/055,365 →
Methods for Identifying Modulators of N-Type Ion Channel Inactivation
Application:
10/051,841 →
Methods for Identifying Modulators of N-Type Ion Channel Inactivation
Application:
10/051,843 →
Aryl sulfonic acids and derivatives as FSH antagonists
Application:
10/043,442 →
Avian embryo particulate biomass for the production of virus antigens
Application:
60/343,339 →
Azaindolylalkylamine derivatives as 5-hyroxytryptamine-6 ligands
Application:
60/342,838 →
Heterocyclylindazole and -Azaindazole Compounds as 5-Hydroxytryptamine-6 Ligands
Application:
10/028,168 →
Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
Application:
60/342,907 →
Heterocyclylalkylindole or -Azaindole Compounds as 5-Hydroxytryptamine-6 Ligands
Application:
10/028,487 →
Mycoplasma hyopneumoniae bacterin vaccine
Application:
10/039,383 →
Methods of Treating Anxiety Disorders
Application:
10/022,579 →
Naphthyl benzoxazoles and benzisoxazoles as estrogenic agents
Application:
60/341,125 →
Substituted indenones as estrogenic agents
Application:
60/341,188 →
Methods for preparing O-desmethyl venlafaxine
Application:
60/334,953 →
Methods for treating arthritic disorders
Application:
60/334,591 →
Inhibitors of cytosolic phospholipase A2
Application:
60/334,588 →
Methods for treating asthmatic conditions
Application:
60/334,605 →
Treatments Using Venlafaxine
Application:
09/996,590 →
Expression Analysis of Kiaa Nucleic Acids and Polypeptides Useful in the Diagnosis and Treatment of Prostate Cancer
Application:
09/996,630 →
Anti-estrogen plus progestin containing oral contraceptives
Application:
09/989,074 →
Ethers of O-Desmethyl Venlafaxine
Application:
09/989,000 →
Enantiomers of N-desmethyl venlafaxine
Application:
09/988,690 →
Genes encoding G-protein coupled receptors and methods of use therefor
Application:
60/332,110 →
Serotonergic Agents
Application:
10/010,575 →
Multifunctional Molecular Complexes for Gene Transfer to Cells
Application:
10/010,114 →
Methods and vaccines for providing in OVO protection against turkey rhinotracheitis
Application:
10/054,288 →
Use of CCI-779 as an antineoplastic agent
Application:
10/010,584 →
Process for the preparation of 2-[alkyl(aryl)]sulfonylbenzenesulfonyl chlorides and their intermediates
Application:
60/332,682 →
Cycloocta[B][1,4]Diazepino[6,7,1-Hi]Indoles and Derivatives
Application:
10/016,228 →
[1,4]Diazepino [6,7,1-Jk] Carbazoles and Derivatives
Application:
10/017,738 →
Cyclohepta [B] [1,4] Diazepino [6,7, 1-Hi] Indoles and Derivatives
Application:
10/016,743 →
Process for the Preparation of 1, 2, 3, 4, 8, 9, 10, 10A-Octahydro-7BH-Cyclopenta[B] [1, 4]Diazepino[6, 7, 1-Hi]Indole Derivatives
Application:
10/016,418 →
Process for the Preparation of 1,2,3,4,8,9,10,10A-Octahydro-7BH-Cyclopenta [B] [1,4] Diazepino- [6,7,1-Hi] Indole Derivatives
Application:
10/016,229 →
Cyclopenta[B][1,4]Diazepino[6,7,1-Hi]Indoles and Derivatives
Application:
10/016,331 →
Process for Preparation of Cyclopenta [B] [1,4] Diazepino [6,7,1-Hi] Indole Derivatives
Application:
10/016,435 →
Processes for Preparation of Cyclopenta [B] [1,4] Diazepino [6,7,1-Hi] Indoles and Derivatives
Application:
10/016,420 →
1-Aryl- or 1-Alkylsulfonyl-Heterocyclylbenzazoles as 5-Hydroxytryptamine-6 Ligands
Application:
10/003,015 →
Removably Replaceable, Readherable Label
Application:
10/002,950 →
1, 3 Disubstituted-2-thioxo-imidazolidine -4,5-dione derivatives useful in the treatment of atherosclerosis
Application:
60/341,046 →
Method and composition for excystation of sporocysts
Application:
60/329,475 →
Antipsychotic Indolyl Derivatives
Application:
09/976,321 →
2-Phenyl-1- [4- (2-Aminoethoxy) -Benzyl] -Indoles as estrogenic agents
Application:
09/974,416 →
[ [2-(Amino-3,4-dioxo-1-cyclobuten-1-yl)amino]alkyl]-acid derivatives for the treatment of pain
Application:
60/328,245 →
Antidepressant chroman and chromene derivatives of 3-(1,2,3,6-tetra-hydro-4-pyridinyl)-1H-indole
Application:
60/328,120 →
Process for the stereoselective synthesis of 2-hydroxymethyl-chromans
Application:
60/327,400 →
Process for the stereospecific synthesis of 2-hydroxymethyl-chromans
Application:
60/327,417 →
Chroman derivatives as 5-hydroxytryptamine-6 ligands
Application:
60/326,957 →
Chroman and benzofuran derivatives as 5-hydroxytryptamine-6 ligands
Application:
60/326,970 →
Method of Providing Coginition Enhancement with 5-Alpha-Pregnan-3-Beta-Ol-20-One Sulfate
Application:
09/971,159 →
Arylpiperazinyl-Cyclohexyl Indole Derivatives for the Treatment of Depression
Application:
09/969,910 →
Amino Thioxomethyl Amino Oxyacetic Acid Derivatives
Application:
09/965,898 →
Imidazo-Isoquinolin-5-One Derivatives, Pyrimido-Isoquinolin-6-One Derivatives and Imidazo-Naphthyridin-5-One Derivatives
Application:
09/965,957 →
3-Thioxo-[1,2,4]-Oxadiazinan-5-One Derivatives
Application:
09/965,874 →
Antibody inhibitors of GDF-8 and uses thereof
Application:
60/324,528 →
Diaminopyrazoles
Application:
09/963,254 →
Enantiomers of O-desmethyl venlafaxine
Application:
09/957,908 →
Method for Identifying Agents That Interact with Beta-Site App Cleaving Enzyme (Bace)
Application:
09/955,737 →
Hydroxyesters of 7-Desmethylrapamycin
Application:
09/955,685 →
Ethers of 7-Desmethylrapamycin
Application:
09/956,322 →
Water Soluble Rapamycin Esters
Application:
09/954,782 →
1-Oxorapamycins
Application:
09/954,880 →
Novel Arylpiperidine and Aryl-1,2,5,6-Tetrahydropyridine Amide Derivatives
Application:
09/954,784 →
Interleukin-12 as a veterinary vaccine adjuvant
Application:
60/322,840 →
Extended Release Formulation
Application:
09/950,965 →
Animal Restraining Device
Application:
09/945,860 →
Structure of a Free Regulator of G-Protein Signaling (RGS4) and Methods of Identifying Agonists and Antagonists Using Same
Application:
09/942,055 →
Endoparasiticidal gel composition
Application:
60/315,104 →
Rapamycin derivatives
Application:
60/314,249 →
Murine genomic polynucleotide sequence encoding a G-protein coupled receptor and methods of use therefor
Application:
60/314,068 →
Rapamycin 29-enols
Application:
60/314,211 →
Methods for screening, treating and diagnosing G-protein coupled receptor-related disorders and compositions thereof
Application:
60/311,684 →
Antineoplastic combinations
Application:
60/310,646 →
Method of Treating Estrogen Receptor Positive Carcinoma
Application:
09/923,217 →
Polymorphs of zaleplon and methods for the preparation thereof
Application:
09/921,017 →
Derivatives of 6-(1,4-diazepan-1-Y1) benzo [CD] indo1-2 (1H) -one
Application:
60/308,650 →
Derivatives of 6 - (1,4-diazepan-1-yl) acenaphthylen-1(2H)-one
Application:
60/308,658 →
6-(Aryl-amido or aryl-amidomethyl) - Naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
Application:
60/308,656 →
Derivatives of 5 - (1.4-diazepan-1-yl) - 2H-naphtho[1,8-CD] isothiazole-1,1-dioxide
Application:
60/308,645 →
Safened equine west nile vaccine
Application:
60/308,334 →
Knock in transgenic mammal containing a non-functional N-terminus of Kv beta1.1 subunit
Application:
60/308,485 →
Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-6H-5-oxa-1-aza-phenanthrene
Application:
60/307,667 →
2-(Aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopental [a] naphthalenyl derivatives with antipsychotic activity
Application:
60/306,931 →
2-(aminomethyl) -tetrahydro-9-oxa-1,3-diaza-cyclopenta [a]naphthalenyl derivatives with antipsychotic activity
Application:
60/306,930 →
Cyclic Amine Phenyl Beta-3 Adrenergic Receptor Agonists
Application:
09/903,754 →
Cyclyamine Sulfonamides as Beta-3 Adrenergic Receptor Agonists
Application:
09/904,158 →
Phenyl Amino Squarate and Thiadiazole Dioxide Beta-3 Adrenergic Receptor Agonists
Application:
09/904,155 →
Substituted 2- (S) -Hydroxy-3- (Piperidin-4-Yl-Methylamino) -Propyl Ethers and Substituted 2-Aryl-2- (R) - Hydroxy-1- (Piperidin-4-Yl-Methyl) -Ethylamine Beta-3 Adrenergic Receptor Agonists
Application:
09/903,738 →
Heterocyclic Beta-3 Adrenergic Receptor Agonists
Application:
09/904,115 →